CLOVER HEALTH INVESTMENTS, CORP. (CLOV) [Rocket]

Overview

CLOVER HEALTH INVESTMENTS, CORP. (CLOV)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
08/10/2023	4	Sharp Aric R (CEO of Value-Based Care) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE
08/09/2023	4	Toy Andrew (CEO) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE
08/08/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/08/2023	8-K	Quarterly results
08/03/2023	8-K	Other Events, Financial Statements and Exhibits  Interactive Data
08/03/2023	DEFA14A	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/26/2023	4	Form 4 - Statement of changes in beneficial ownership of securities:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19
Revenues	3,476.7	1,472.0	672.9	462.3
Revenue growth	136.2%	118.8%	45.6%
Cost of goods sold	278.7	1,551.2	0.0	0.0
Gross profit	3,198.0	-79.2	672.9	462.3
Gross margin	92.0%	-5.4%	100.0%	100.0%
General and administrative	207.9	445.7	192.1	187.3
EBITA	-370.9	-636.3	-92.7	-183.2
EBITA margin	-10.7%	-43.2%	-13.8%	-39.6%
Amortization of intangibles		0.7
EBIT	-370.9	-637.0	-92.7	-183.2
EBIT margin	-10.7%	-43.3%	-13.8%	-39.6%
Pre-tax income	-338.8	-587.8	-136.4	-363.7
Income taxes	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%
Net income	-338.8	-587.8	-136.4	-363.7
Net margin	-9.7%	-39.9%	-20.3%	-78.7%

Diluted EPS		($1.42)	($1.54)	($4.14)
Shares outstanding (diluted)		412.9	88.7	87.8

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.